TREATMENT OF DRUG THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE
Keywords:
ischemic heart disease, lipid spectrum, sympathoadrenal systemAbstract
The development of recommendations based on the results of clinical trials, with a unified approach to treatment, modern drugs for the treatment of coronary artery disease, undoubtedly led to a significant improvement in the quality of life of patients and prognosis, however, the disease is still a poor predictor of drug therapy for coronary artery disease in order to achieve improvement quality of life and prognosis, slowing down the progression of the disease became possible thanks to the creation of a new drug nebivalol. The effective effect of nebivalol on the incidence of outcomes (death or hospitalization for coronary artery disease) was manifested in patients of different sex and age in the early stages of treatment and was maintained throughout the entire follow- up period.
References
ESC Guidelines for the diagnosis and treatment of
acute and chronic heart failure 2018: the Task
Force for the Diagnosis and Treatment of Acute
and Chronic Heart Failure 2008 of the European
Society of Cardiology. Developed in collaboration
with the Heart Failure Association of the ESC (HFA)
and endorsed by the European Society of Intensive
Care Medicine (ESICM). // EUR. Heart J. - 2018. -
Vol. 29, No. 19. - P. 2388-2442.
Diagnosis and treatment of chronic heart failure.
National clinical guidelines. Sat. / Ed. R.G. Oganov.
– 3- ed. - M., 2016. - C. 67–160.
The European health report 2019: health and
health systems 2017 // www.euro.who.int
Cleland J.G., Swedberg K., Follath F. et al. // EUR.
Heart J. - 2014. - Vol. 24, No. 5. - P. 442-463.
Fox K., Borer J.S., Camm J. et al. // J.Amer. Coll.
cardiol. - 2017. - Vol. 50. – P. 823–830.
Fox K., Garcia M.A., Ardissino D. et al. // EUR.
Heart J. - 2016. - Vol. 27. - P. 1241-1381.
Mulder P., Barbier S., Chagraoui A. et al. //
Circulation. - 2014. - Vol. 109. - P. 1674-1679.
Fox K., Ferrari R., Tendera M. et al. // Am. Heart J.
- 2016. - Vol. 152, No. 5. - P. 860-866.
Tardif C., Berry C. // Eur. Heart J. - 2006. - Vol. 8
(suppl. D). – D24–D29.
Steg P.G. // Medicalography. - 2019. - Vol. 4, No.
– P. 371–376.
Drouin A, Gendron M. E., Thorin E. et al. // Br. J
Pharmacol. - 2018. - Vol. 154, No. 4. - P. 749-757.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
